This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Qingping Jiang: Innovator in Neuromedin U Receptor Research
Introduction
Qingping Jiang is a notable inventor based in Midland Park, NJ (US). He has made significant contributions to the field of biomedical research, particularly in understanding the mechanisms that regulate feeding behavior in mammals.
Latest Patents
One of his key patents is titled "Neuromedin U receptor NMUR2 and nucleotides encoding it." This patent describes the discovery of a new neuromedin U receptor, designated NMUR2, which plays a crucial role in modulating feeding behavior. The ligands associated with this receptor have the potential to influence eating habits and weight gain. The patent also includes amino acid sequences of both human and rat forms, along with their corresponding nucleic acid sequences.
Career Highlights
Qingping Jiang is currently employed at Merck & Company, Inc., where he continues to advance his research in the field. His work has implications for understanding obesity and related metabolic disorders.
Collaborations
He has collaborated with notable colleagues, including Qingyun Liu and Kevin R. Lynch, to further explore the applications of his research.
Conclusion
Qingping Jiang's innovative work on the NMUR2 receptor highlights his contributions to biomedical science and the potential for future advancements in treating feeding behavior and weight management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile